R&G Pharma Studies, a Beijing, China-based CRO, has broadened its adoption of Medidata's Clinical Cloud, becoming the first Chinese customer to use Medidata CTMS. R&G provides a full range of clinical trial services including regulatory affairs, clinical monitoring, data manageOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.